% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • ampiooooooh ampiooooooh Jan 30, 2013 1:03 PM Flag

    why ampe is undervalued - response to ampiooooooh


    Now can you explain how you think AMPE could have done a Phase 3 study of Zertane in the US without it being posted on the FDA website.....

    Too funny

    "My understanding is that the final phase III trial has already been completed and that they are only waiting for the FDA's response. I believe these trials took place in the U.S. recently."

    Were these studies posted on the FDA clinical trials website? No......

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • yes . . .you are correct that a search into would reveal any trial in the u.s. and zertane has not been done in the u.s. there was a great deal of uncertainty that the company still has not clarified about macalusos comments from the noble presentation the other day.

      in the recent noble presentation, macaluso said that the questionnaire portion of the trial has been done and they are waiting to hear from the fda. once the fda approves it, assuming it is approved and not denied, then their pharma partner, if they are still interested, will take over the phase III trial that will probably go fairly quickly.

      Sentiment: Strong Buy

      • 1 Reply to racavalli
      • mjakobczak9 Jan 30, 2013 1:34 PM Flag

        Zertane could still do very well, even outside the US. They have licensing in Brazil and many other countries. But in Brazil, life is all about sex and food. Men spend countless dollars on helping fix their ED. Just need this US approval and I think it will be very great news.
        This sell-off and the short article published yesterday is pretty much criminal. I e-mailed the board of directors though at Ampio. Will see what they say.

        Sentiment: Strong Buy

0.954-0.0031(-0.32%)Jul 25 4:02 PMEDT